mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.026 |
0.7 |